The About Us webpage (11/27/17) advertises "global presence ... to take the high quality research work close to a wide range of ... communities." Too close for comfort perhaps. SciTechnol claims to have "104 Hybrid Access online Journals, ... 1500 Editorial team, 2 Million readers, ... More than 50,000 Facebook Likes."
The first Scitechnol journal that spammed me (on 12/20, 21, 22, 26/16) was the Journal of Forensic Toxicology and Pharmacology (JFTP). It manages to combine "all areas related to Forensic Toxicology, Digital Forensics, Forensic Chemistry, Pharmacokinetics and Pharmacology on quarterly basis. ... Papers will be published approximately 15 days after acceptance." Apparently, "papers" covers a lot. "SciTechnol accepts various formats of literary works such as ... abstracts, addendums, announcements, ... annual meeting abstracts, conference proceedings, calendars, ... corrections, discussions, meeting-reports, news, obituaries, orations, product reviews, hypotheses and analyses."
The names and photos listed for JFTP editors from the US are James T Pokines, PhD, Department of Anatomy and Neurobiology, Boston University (who is "the Forensic Anthropologist for the Commonwealth of Massachusetts, Office of the Chief Medical Examiner, Boston"); Karl A Larsen, PhD, University of Illinois at Chicago; John Zheng Wang, PhD, California State University-Long Beach (a featured speaker in BIT Global's flaky conferences); Donald Siwek, PhD, Department of Anatomy and Neurobiology, Boston University; Fred Smith, PhD, Department of Forensic Science, University of New haven [sic]; Harvey J.M. Hou, Ph.D, Alabama State University; Lisa Reidy, PhD, Division of Clinical Pathology, University of Miami; Thomas A. Brettell, PhD, Cedar Crest College, USA; Elizabeth Laposata, Boston University; Marilyn T. Miller, Department of Forensic Science, Virginia Commonwealth University; George Thomas, Department of criminal justice & Forensic sciences, Albany state university; Jeff Hackett, United Chemical Technologies, USA ("Research interest: toxicologist").
If this journal has an editor-in-chief, it has not chosen to reveal his or her identity on the website.
Journal of Clinical Images and Case Reports
- From: Journal of Clinical Images & Case Reports
Sent: Wed 3/7/2018 5:23 AM
Subject: Appreciation for Your Effective work || Case Reports || Clinical Images
Dear Dr. David Kaye,
It is our pleasure to announce that Journal of Clinical Images and Case Reports has successfully entered its 2nd year of its publication journey and we are aiming to index it in SCIE by publishing peer reviewed, quality articles. We wish to continue to publish high quality articles and need your contribution in the form of Research articles/Case reports/Clinical Images/ Short Communications/ Letter to Editor/ Commentary relevant to, but not limited to clinical and medicinal field.
I appreciate your submission to Case Reports on or before 28 March 2018. However, we may extend the time limit if you intimate us regarding the submission. ...
Best wishes for your continuing research. Hope for a long lasting scientific relationship with you.
Journal Coordinator, Clinical Images and Case Reports, 5716 Corsa Ave, Suite 110, Westlake, Los Angeles
CA 91362-7354, USA, Tel: +1-650-618-1414, E-mail: Clinicalimages@scitechnol.com
- 12/20/16: Greetings from Journal of Forensic Toxicology and Pharmacology. We have gone through your publication entitled “The design of “the first experimental study exploring DNA interpretation”” and are very impressed by it. We would like to know your availability of submitting such other interesting articles to our journal’s upcoming issue. ... It would be great if you submit your manuscript on or before January 15th,
2017 ... . Please revert back for any other queries. Regards, Maddula K, Journal Coordinator
Journal of Forensic Toxicology and Pharmacology, SciTechnol, 5716 Corsa Ave, Suite 110, Westlake,Los Angeles, CA 91362-7354, USA, Tel: +1 702-714-7001 (9039) extn
- 12/21/16, 12/22/16: Dear David H. Kaye, Greetings from Journal of Forensic Toxicology and Pharmacology. We have gone through your publication entitled “The good, the bad, the ugly: The NAS report on strengthening forensic science in America” and are very impressed by it. ... Please revert back for any other queries. [Identical text] Regards, Maddula K ...
- 12/26/16: Dear David H. Kaye, Greetings from Journal of Forensic Toxicology and Pharmacology. We have contacted you earlier through email and since we did not have the pleasure of your ensuing correspondence; we are taking the liberty of resending the mail. We are aware that you may be engaged in other activities or our message may not have successfully reached you. We would be pleased if you can spare us some time and revert back at the earliest. We have gone through your publication entitled “The good, the bad, the ugly: The NAS report on strengthening forensic science in America” and are very impressed by it. ... Please revert back for any other queries. Regards, Maddula K ...
From: Journal of Veterinary Science and Medical Diagnosis [firstname.lastname@example.org]
Sent: Monday, November 27, 2017 2:06 AM
Subject: Recent Updates in Veterinary Dear Researcher, Greeting from Veterinary Science and Medical Diagnosis!! Journal of Veterinary Science and Medical Diagnosis is a hybrid journal ... Based on research interest which is within the scope of our journal, we have chosen some experts to encourage the current research and make it available to students, researchers, scientists worldwide. In this moment we found your profile with good in the current research era and gone through your recent publications which are novel. We appreciate you for your work in the current emerging trend. We are pleased to invite you to write an article or short review based on your expertise for publication in the forthcoming issue. ... Submission Last date: December 15, 2017. We hope your research work will trend to new innovation and success.
Thanks and best regards, Journal Coordinator, E-mail: email@example.com | firstname.lastname@example.org SciTechnol Tel: +1 702 714 7001 extn: 9039/9043l